Kayentis Launches Fully Integrated Platform for Decentralized Clinical Trials

Kayentis, a global provider of eCOA and Decentralized Clinical Trial solutions, has announces the launch of a fully integrated patient-centric platform that optimizes the management of hybrid and Decentralized Clinical Trials (DCT).

This streamlined platform alleviates many logistical hurdles in bringing key elements of the clinical trial to patients’ homes, while vastly improving how patients and sites use DCT technologies. Stakeholders in remote clinical trials gain seamless access to a wide panel of robust functionalities all within the same platform. These include various modes of data collection, such as BYOD, WebCOA, provisioned devices, and data entry by phone; as well as an easy-to-use telemedicine app. Embedded features that enable active patient engagement are also included, with options to integrate other functions in the future, the company said.

“Kayentis’ new streamlined platform features make remote clinical trials much easier for patients, sites, CROs and sponsors to manage; the simplified access to options considerably reduces patient burden,” said Guillaume Juge, CEO at Kayentis. “We have been expanding our DCT services in step with the growing demand for hybrid and decentralized clinical trials. This added capacity enables our operational teams across Europe, the US and Asia to attract wider interest in our digital capabilities.”